Clinical and experimental evidence of Bcl-2 involvement in the response to photodynamic therapy

Anticancer Research

Volumn 21, Issue 1 B, 2001, Pages 663-668

  Koukourakis, M I ^a   Corti, L ^a   Skarlatos, J ^a   Giatromanolaki, A ^a   Krammer, B ^a   Blandamura, S ^a   Piazza, M ^a   Verwanger, T ^a   Schnitzhofer, G ^a   Kostandelos, J ^a   Beroukas, K ^a  

^a Tumour and Angiogenesis Research Group Iraklion   (Greece)

Author keywords

Bcl 2 and p53; Esophageal cancer; Photodynamic therapy; Radiotherapy

Indexed keywords

HEMATOPORPHYRIN DERIVATIVE; PROTEIN BCL 2; PROTEIN P53;

ADULT; AGED; ARGON LASER; ARTICLE; CANCER RADIOTHERAPY; CANCER SURVIVAL; CLINICAL ARTICLE; CYTOTOXICITY; ESOPHAGUS CANCER; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TREATMENT OUTCOME;

ADULT; AGED; APOPTOSIS; ARGON; CARCINOMA, SQUAMOUS CELL; CELL LINE, TRANSFORMED; CELLS, CULTURED; COMBINED MODALITY THERAPY; DISEASE-FREE SURVIVAL; DRUG RESISTANCE; ESOPHAGEAL NEOPLASMS; FEMALE; FIBROBLASTS; HEMATOPORPHYRIN DERIVATIVE; HUMANS; LASERS; MALE; MIDDLE AGED; NEOPLASM PROTEINS; PHOTOCHEMOTHERAPY; PROTO-ONCOGENE PROTEINS C-BCL-2; SURVIVAL ANALYSIS; TREATMENT OUTCOME; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0035065142     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. p21 is necessary for the p53-mediated Gl arrest in human cancer cells
2. Prevention of programmed cell death of sympathetic neurons by the bcl-2 protooncogene
3. bcl-2 in normal human breast and carcinoma; association with oestrogen receptor-positive; epidermal growth factor receptor negative tumors and in situ cancer
4. Potential role of bcl-2 as a suppressor of tumor angiogenesis in non small cell lung cancer
5. Bcl-2 expression correlates with favourable outcome in head and neck cancer treated by accelerated radiotherapy
6. Combined role of angiogenesis, bcl-2 and p53 expression in the prognosis of colorectal cancer
7. Radiation-induced cell cycle arrest compromised by p21 deficiency
8. p53 directly enhances rejoining of DNA double-strand breaks with cohesive ends in γ-irradiated mouse fibroblasts
9. Modulation of expression of p53 and cell proliferation in locally advanced cervical carcinoma after, neoadjuvant combination chemotherapy
10. Overexpression of p53 predicts organ preservation using induction chemotherapy and radiation in patients with advanced laryngeal cancer. Departrnent of Veterans Affairs Laryngeal Cancer Study Group
11. Photodynamic therapy of colorectal cancer using a new light source: From in vitro studies to a patient treatment
12. Photodynamic therapy of oral cancer. A review of basic mechanisms and clinical applications
13. Enhanced apoptotic response to photodynamic therapy after bcl-2 transfection
14. The induction of partial resistance to photodynamic therapy by the protooncogene bcl-2
15. Photodynamic therapy sensitivity is not altered in human tumor cells after abrogation of p53 function
16. Differential photosensitivity in wild type and mutant p53 human colon carcinoma cell lines
17. Long term survival of patients with early oesophageal cancer treated with photodynamic therapy and radiotherapy
18. p53 and bcl-2 expression in locally advanced squamous cell head-neck cancer treated with platinum based chemotherapy and radiotherapy
19. Photodynamic therapy of oesophageal carcinoma
20. Long-term survival after photodynamic therapy for esophageal cancer
21. Photodynamic therapy results in p53-independent induction of WAF1/CIP1/P21, leading to cell cycle arrest and apoptosis
22. Prevention of apoptosis by bcl-2: Release of cytochrome c from mitochondria blocked
23. Cytochrom c and dATP-dependent formation of apaf-1/caspase-9 complex initiates an apoptotic protease cascade
24. Photodynamic therapy: A mitochondrial inducer of apoptosis
25. Cell suicide in health and disease
26. Bcl-2 is the guardian of microtubule integrity